Pharmaphorum provides news and analysis on the pharmaceutical and biotech industries, focusing on trends, insights, and expert opinions.

Pharmaphorum

Pharmaceutical Manufacturing

pharmaphorum publishing

pharmaphorum | 10,605 followers on LinkedIn. Industry leading publications, strategic consulting and a content-driven stakeholder engagement agency | pharmaphorum.com, and its associated digital magazine Deep Dive, is a leading online destination for healthcare and pharmaceutical industry news, insight and debate.
www.pharmaphorum.com

Entrepreneur - Healthcare Recruitment, Digital Communication Platforms, Social Media Publishing and Research

Dr Mo Sacoor

Matthew (Matt) Brookes

Deep Dive editor at pharmaphorum

Eloise McLennan

pharmaphorum

In today’s daily newsletter https://lnkd.in/dQyWGJJ3 🚑 Find out what Trump’s election win means for the health insurance of millions of Americans. 🧬 Learn more about Autolus’ leukaemia cell therapy. 😷 Discover what EHRs can tell us about undiagnosed long COVID. 💰 Digital pathology’s in amongst the week’s digital health financings. 🔎 Delve into J&J’s positive Ph3 data in smouldering multiple myeloma. 🔬 💻 Sink your teeth into the evolving role of AI in drug development <- long read

In this week’s top stories, we hear that Alligator Bioscience AB ’s pancreatic cancer drug 'nearly doubles' survival. Meanwhile, need it be said, Donald Trump claimed comprehensive victory in the US election and is to be the 47th President. We look at the potential impact on US citizens, as well as pharma. Novo Nordisk abandoned a drug it licensed from KBP Biosciences last year in a deal valued at up to $1.3 billion after it missed the mark in a chronic kidney disease trial. The UK Sudlow Review was also released, damning the state of the country’s health data ecosystem. And AstraZeneca confirmed its China president had been detained. Discover more in our weekly Top Stories newsletter

It is crucial to think of “AI native” processes or processes with intrinsic and trustworthy #AI capabilities for achieving scalable outcomes, says eClinical Solutions' Raj Indupuri . Leveraging AI for a discrete set of use cases risks falling behind in a rapidly evolving landscape. #biopharma https://lnkd.in/eGzuVunJ

#Psychedelictherapies have emerged as a promising frontier in #mentalhealth treatment, sparking interest from researchers and investors - but Ben Hargreaves finds the FDA Lykos rejection raises fresh concerns about a future path to #regulatory approval. https://lnkd.in/ePnKp6aZ

The responsible, #ethical , and transparent application of #AI in #drugdiscovery and development will be a critical component of its ultimate success. #Pharma must ensure their AI models are built on high-quality #trainingdata , and rigorously validated. Elsevier's Mirit Eldor discusses. https://lnkd.in/edCc3efF

In a fresh #podcast , Matt Hollingsworth , co-founder and CEO of Carta Healthcare, a company seeking to support the #healthcare data registry market by transforming a previously manual #clinicaldata abstraction process, discusses #digitalhealthpassports . https://lnkd.in/eiFSwu2A

In a new #podcast , Dr Evan Floden , CEO and co-founder of Seqera, discusses barriers of entry to #genomicsurveillance in public health labs and how these can be lowered to support future #bioinformaticians . https://lnkd.in/efkYcava

While linguistic #diversity enriches societies, it also presents challenges, particularly in the #healthcare sector, where #languagebarriers can impede effective communication between #medicalpractitioners and #patients . Neil Berry of Babbel for Business explains the importance of language learning in the sector. https://lnkd.in/ehcnHx5Q

🎞️ This Week's Key Topics in Life Sciences: 👔 Corporate & Regulatory: AstraZeneca executive Leon Wang detained in China; Eisai lowers expectations for Alzheimer’s drug Leqembi. 🤝 Partnerships & Deals: Daiichi Sankyo Europe GmbH Sankyo and Alteogen partner for a $300M subcutaneous Enhertu project. 🧬 Genomics & Health Data: NHS Wales teams up with Illumina for cancer genomics; Sudlow Review criticises UK’s health data infrastructure. 👉 Find more stories at https://lnkd.in/dVs5J-6X

PHAR

COM:PHARMAPHORUM

Pharmaphorum